Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye

Table 1

Clinical data of CNV patients treated by oral bisphosphonate.

CNV type	AMD	Pathological myopia
Age (years)	$76.0\pm 9.0$	$64.4\pm 8.7$
Gender (male/female)	20/4	2/10
Baseline LogMAR BCVA	$0.75\pm 0.46$	$0.53\pm 0.34$

BCVA: best corrected visual acuity, LogMAR: logarithm of the minimum angle of resolution.